When Drugs Become Warning Signs: Mass Torts, Ozempic & What’s Coming Next
Ozempic and similar GLP-1 drugs are fueling a wave of mass tort litigation. In this Trial Lawyer View episode, Michael Lynch shares what trial lawyers need to know about emerging claims, signature injuries, and strategies to hold pharmaceutical companies accountable.